PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 S 4(th) Street, Hamilton, MT 59840, USA.\', \'Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.\', \'Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 S 4(th) Street, Hamilton, MT 59840, USA; University of Plymouth, Plymouth, Devon, UK; The Vaccine Group Ltd, Plymouth, Devon, UK.\', \'Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 S 4(th) Street, Hamilton, MT 59840, USA. Electronic address: kyle.rosenke@nih.gov.\', \'Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 S 4(th) Street, Hamilton, MT 59840, USA. Electronic address: feldmannh@niaid.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-1247(22)00251-010.1016/j.celrep.2022.110515
?:doi
?:hasPublicationType
?:journal
  • Cell reports
is ?:pmid of
?:pmid
?:pmid
  • 35263638
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.552
?:rankingScore_hIndex
  • 92
?:title
  • SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all